RESUMO
The authors report their experience in the use of somatostatin in severe acute pancreatitis. From 1985 to 1990, 169 patients with severe acute pancreatitis have been observed in the Surgery Division of "S. Andrea" Hospital in Vercelli. After the introduction, the evaluation of methods employed and results obtained, the authors conclude that somatostatin can give a good response in this kind of patient without side effects or complications.
Assuntos
Pancreatite/tratamento farmacológico , Somatostatina/administração & dosagem , Doença Aguda , Terapia Combinada , Avaliação de Medicamentos , Feminino , Humanos , Infusões Intravenosas , MasculinoRESUMO
The authors report their experience about the use of the timostimoline in the perioperative time in 114 cases of gastric and rectum cancer. They think that this method can be of help for neoplastic patients about the time of surgical stress.
Assuntos
Adjuvantes Imunológicos/uso terapêutico , Neoplasias Colorretais/terapia , Cuidados Pré-Operatórios , Neoplasias Gástricas/terapia , Extratos do Timo/uso terapêutico , Terapia Combinada , Humanos , Estresse Fisiológico/terapiaRESUMO
The paper illustrates the Authors' personal experience of the use of somatostatin in high digestive hemorrhages. Endoscopy continues to be the principal method for hemorrhage diagnosis and therapy and the additional use of somatostatin undoubtedly accelerates recovery by blocking gastric and pancreatic secretions and blood flow at the splanchnic level.
Assuntos
Hemorragia Gastrointestinal/tratamento farmacológico , Somatostatina/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Úlcera Duodenal/complicações , Varizes Esofágicas e Gástricas/complicações , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera Péptica Hemorrágica/tratamento farmacológico , Úlcera Gástrica/complicaçõesRESUMO
Sclerosing cholangitis is a rare liver disease of unknown etiology with a slow but progressive course. The authors report their experience and illustrate some surgical procedures to preserve bile duct patency in view of a liver transplantation program.